Total planned funding: $212,034,289
Allocations
Countries/Regions
Ukraine | $212,034,289 |
Organizational Types
Unknown | $61,026,335 |
NGO | $49,048,369 |
Private Contractor | $36,243,894 |
Own Agency | $29,354,620 |
Multi-lateral Agency | $12,925,607 |
University | $10,677,000 |
Implementing Agency | $6,725,040 |
Other USG Agency | $4,183,424 |
Host Country Government Agency | $1,850,000 |
Program Areas
Governance and Systems | $90,221,711 |
Treatment | $36,646,118 |
Prevention | $24,760,891 |
Testing | $22,281,487 |
Management and Operations | $21,209,203 |
Care | $16,914,879 |
Budget Codes
OHSS: Health Systems Strengthening | $52,648,945 |
HTXS: Treatment: Adult Treatment | $24,082,123 |
HVSI: Strategic Information | $23,347,206 |
HVCT: Testing: HIV Testing and Counseling | $22,281,487 |
HVMS: Management and Operations | $21,209,203 |
HLAB: Laboratory Infrastructure | $14,225,560 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $12,573,385 |
HTXD: Treatment: ARV Drugs | $12,563,995 |
HVTB: Care: TB/HIV | $9,397,954 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,733,723 |
HBHC: Care: Adult Care and Support | $4,348,732 |
HKID: Care: Orphans and Vulnerable Children | $3,168,193 |
HMBL: Biomedical Prevention: Blood Safety | $2,687,636 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $222,790 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$57,256,335
Countries/Regions
USG Aggregated Agencies:
$22,821,297
Countries/Regions
Chemonics International:
$20,772,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions